Citation: Jia-Yin Su, Shiyao Song, Zi-Min Song, Xi Sun, Niangji Tsomo, Ying-Li Liu, Jingxuan Ma, Jie-Si Luo, Li-Na Wang, Suoyu Xiang, Cong Liang, Xue-Qun Luo, Jun Wu, Li-Bin Huang, Yan-Lai Tang. Arsenic trioxide-induced pyroptosis promotes the release of HMGB1 to activate natural killer cells related immunogenic cell death in leukemia[J]. Chinese Chemical Letters, ;2026, 37(7): 111585. doi: 10.1016/j.cclet.2025.111585 shu

Arsenic trioxide-induced pyroptosis promotes the release of HMGB1 to activate natural killer cells related immunogenic cell death in leukemia

Jia-Yin Su ^{a, d, 1} ,
Shiyao Song ^{a, 1} ,
Zi-Min Song ^b ,
Xi Sun ^c ,
Niangji Tsomo ^e ,
Ying-Li Liu ^f ,
Jingxuan Ma ^g ,
Jie-Si Luo ^a ,
Li-Na Wang ^a ,
Suoyu Xiang ^c ,
Cong Liang ^a ,
Xue-Qun Luo ^a ,
Jun Wu ^{h, i, *,} ,
Li-Bin Huang ^{a, *,} ,
Yan-Lai Tang ^{a, *,}

a.
Department of Paediatrics, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China
b.
Center of Hepato-Pancreato-Biliary Surgery, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China
c.
Department of Parasitology of Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China
d.
School of Life Science, The Chinese University of Hong Kong, Hong Kong SAR 999077, China
e.
Research Center for High Altitude Medicine, School of Medicine, Qinghai University, Xining 810000, China
f.
Shenzhen Longgang Otorhinolaryngology Hospital, Shenzhen 518100, China
g.
West China School of Medicine, Sichuan University, Chengdu 610044, China
h.
Division of Life Science, The Hong Kong University of Science and Technology, Hong Kong SAR 999077, China
i.
Bioscience and Biomedical Engineering Thrust, The Hong Kong University of Science and Technology (Guangzhou), Guangzhou 511400, China

junwuhkust@ust.hk

huanglb3@mail.sysu.edu.cn

tangylai@mail.sysu.edu.cn

Received Date: 16 April 2025
Revised Date: 11 July 2025
Accepted Date: 13 July 2025
Available Online: 14 July 2025

Figures(4)

The application of Arsenic trioxide (ATO) has greatly improved the cure rates in patients with acute promyelocytic leukemia (APL) and has shown therapeutic effects in other leukemia types, as evidenced by an increasing number of preclinical trials. However, its clinical application is still limited due to a lack of understanding of the underlying mechanisms. In this report, we have demonstrated that ATO can induce pyroptosis and release damage-associated molecular patterns (DAMPs), such as high mobility group box 1 (HMGB1) and interleukin-1β (IL-1β). DAMPs can activate the immunogenic cell death (ICD) mechanism. Our study elucidated the pivotal role of pyroptosis and demonstrated the activation of the caspase-3/gasdermin E (GSDME) pathway both in vivo and in vitro upon ATO intervention. Proteomic analysis of cell supernatants revealed the release of the ICD-associated molecule HMGB1. Results from both in vitro and in vivo experiments collectively demonstrated that the release of HMGB1 is contingent upon GSDME-mediated pyroptosis. Furthermore, label-free quantitative proteomics in vivo indicated that ATO-induced pyroptosis activates natural killer cells (NKs) and promotes the release of granzyme B (GZMB). Our study is the first to demonstrate the synergistic interplay between pyroptosis and ICD mechanisms during ATO treatment, providing novel insights into the potential of ATO for immunotherapy and synergistic treatment approaches.
- Arsenic trioxide,
- Pyroptosis,
- Natural killer cells,
- Acute myeloid leukemia,
- Immunogenic cell death
1. [1]
  E. Lengfelder, W.K. Hofmann, D. Nowak, Leukemia 26 (2012) 433–442. doi: 10.1038/leu.2011.245
2. [2]
  F. LoCoco, G. Avvisati, M. Vignetti, et al., N. Engl. J. Med. 369 (2013) 111–121. doi: 10.1056/NEJMoa1300874
3. [3]
  J.S. Luo, X.L. Zhang, D.P. Huang, et al., Ann. Hematol. 102 (2023) 1713–1721. doi: 10.1007/s00277-023-05270-x
4. [4]
  D.P. Huang, L.C. Yang, Y.Q. Chen, et al., Blood Cancer J. 13 (2023) 178. doi: 10.1080/0268117x.2022.2134917
5. [5]
  C.J. Peng, Z. Fan, J.S. Luo, et al., Technol. Cancer Res. Treat. 23 (2024) 15330338231223080. doi: 10.1177/15330338231223080
6. [6]
  M. Sonksen, K. Kerl, H. Bunzen, Med. Res. Rev. 42 (2022) 374–398. doi: 10.1002/med.21844
7. [7]
  X. Li, Y.F. Pan, Y.B. Chen, et al., Cell Death Dis. 15 (2024) 300. doi: 10.1038/s41419-024-06685-8
8. [8]
  K. Moloudi, A. Neshasteriz, A. Hosseini, et al., Iran Biomed. J. 21 (2017) 330–337. doi: 10.18869/acadpub.ibj.21.5.330
9. [9]
  P.R. Subbarayan, B. Ardalan, J, Gastrointest. Cancer 45 (2014) 363–371. doi: 10.1007/s12029-014-9617-8
10. [10]
  J. Shi, Y. Zhao, K. Wang, et al., Nature 526 (2015) 660–665. doi: 10.1038/nature15514
11. [11]
  J. Gao, X. Zhang, K. Shang, et al., Chin. Chem. Lett. 31 (2020) 427–430. doi: 10.1016/j.cclet.2019.09.020
12. [12]
  S.M. Man, R. Karki, T.D. Kanneganti, Immunol. Rev. 277 (2017) 61–75. doi: 10.1111/imr.12534
13. [13]
  J. Ding, K. Wang, W. Liu, et al., Nature 535 (2016) 111–116. doi: 10.1038/nature18590
14. [14]
  J. Shi, W. Gao, F. Shao, Trends Biochem. Sci. 42 (2017) 245–254. doi: 10.1016/j.tibs.2016.10.004
15. [15]
  G. Zhong, F. Wan, J. Lan, et al., Sci. Total Environ. 788 (2021) 147780. doi: 10.1016/j.scitotenv.2021.147780
16. [16]
  L.L. Zhang, D.J. Zhang, J.X. Shi, et al., Phytomedicine 132 (2024) 155828. doi: 10.1016/j.phymed.2024.155828
17. [17]
  A.D. Garg, P. Agostinis, Immunol. Rev. 280 (2017) 126–148. doi: 10.1111/imr.12574
18. [18]
  J. Wen, X. Zhang, Front. Biosci. 28 (2023) 260. doi: 10.31083/j.fbl2810260
19. [19]
  Y. Gao, R. Zhou, Q. Wang, et al., Chin. Chem. Lett. 35 (2024) 109521. doi: 10.1016/j.cclet.2024.109521
20. [20]
  F. Shao, Nat. Rev. Immunol. 21 (2021) 620–621. doi: 10.1038/s41577-021-00602-2
21. [21]
  A. Coppola, B. Capuani, F. Pacifici, et al., Int. J. Mol. Sci. 22 (2021) 7988. doi: 10.3390/ijms22157988
22. [22]
  G. Bossi, G.M. Griffiths, Nat. Med. 5 (1999) 90–96. doi: 10.1038/4779
23. [23]
  Z. Zhang, Y. Zhang, S. Xia, et al., Nature 579 (2020) 415–420. doi: 10.1038/s41586-020-2071-9
24. [24]
  Z. Zhou, H. He, K. Wang, et al., Science 368 (2020) 6494.
25. [25]
  T. Hoegen, N. Tremel, M. Klein, et al., J. Immunol. 187 (2011) 5440–5451. doi: 10.4049/jimmunol.1100790
26. [26]
  B. Zhou, D.W. Abbott, Cell Rep. 35 (2021) 108998. doi: 10.1016/j.celrep.2021.108998
27. [27]
  H.H. Zhu, Y.Z. Qin, Z.L. Zhang, et al., Blood Adv. 7 (2023) 2972–2982. doi: 10.1182/bloodadvances.2022008364
28. [28]
  B.L. MundyBosse, S.D. Scoville, L. Chen, et al., J. Clin. Invest. 126 (2016) 4404–4416. doi: 10.1172/JCI85413
29. [29]
  A. Ahmed, S.W.G. Tait, Mol. Oncol. 14 (2020) 2994–3006. doi: 10.1002/1878-0261.12851
30. [30]
  D.V. Krysko, A.D. Garg, A. Kaczmarek, et al., Nat. Rev. Cancer 12 (2012) 860–875. doi: 10.1038/nrc3380
31. [31]
  Y. Cui, X. Wu, J. Jin, et al., Mol. Cancer 22 (2023) 179. doi: 10.1093/jrsssb/qkac001
32. [32]
  M.T. Lotze, K.J. Tracey, Nat. Rev. Immunol. 5 (2005) 331–342. doi: 10.1038/nri1594
33. [33]
  A. Murao, M. Aziz, H. Wang, M. Brenner, P. Wang, Apoptosis 26 (2021) 152–162. doi: 10.1007/s10495-021-01663-3
34. [34]
  M. Lamkanfi, A. Sarkar, L. Vande Walle, et al., J. Immunol. 185 (2010) 4385–4392. doi: 10.4049/jimmunol.1000803
35. [35]
  L. Hou, Z. Yang, Z. Wang, et al., Lab. Invest. 98 (2018) 1052–1064. doi: 10.1038/s41374-018-0073-0
36. [36]
  Y. Masuda, M. Futamura, H. Kamino, et al., J. Hum. Genet. 51 (2006) 652–664. doi: 10.1007/s10038-006-0004-6
37. [37]
  M.B. Düzgün, K. Theofilatos, A.G. Georgakilas, A. Pavlopoulou, Oxid. Med. Cell Longev. 2019 (2019) 4606219.
38. [38]
  L. Jayaraman, N.C. Moorthy, K.G. Murthy, et al., Genes Dev. 12 (1998) 462–472. doi: 10.1101/gad.12.4.462
39. [39]
  W.O. Chae, G.D. Kim, J. Cancer Prev. 26 (2021) 183–194. doi: 10.13041/jpvm.2021.45.4.183
40. [40]
  H. Lin, Y. Wang, H. Lai, X. Li, T. Chen, Chem. Asian J. 13 (2018) 2730–2738. doi: 10.1002/asia.201800862
41. [41]
  C. Rogers, T. FernandesAlnemri, L. Mayes, et al., Nat. Commun. 8 (2017) 14128.
42. [42]
  S. Kumar, M. Dhiman, Microb. Pathog. 125 (2018) 468–474. doi: 10.1016/j.micpath.2018.10.012
43. [43]
  A. Chevriaux, T. Pilot, V. Derangère, et al., Front. Cell Dev. Biol. 8 (2020) 167.
1. [1]
  Jisheng Liu , Junli Chen , Xifeng Zhang , Yin Wu , Xin Qi , Jie Wang , Xiang Gao . Red blood cell membrane-coated FLT3 inhibitor nanoparticles to enhance FLT3-ITD acute myeloid leukemia treatment. Chinese Chemical Letters, 2024, 35(9): 109779-. doi: 10.1016/j.cclet.2024.109779
2. [2]
  Weijian Zhang , Xianyu Deng , Liying Wang , Jian Wang , Xiuting Guo , Lianggui Huang , Xinyi Wang , Jun Wu , Linjia Jiang . Poly(ferulic acid) nanocarrier enhances chemotherapy sensitivity of acute myeloid leukemia by selectively targeting inflammatory macrophages. Chinese Chemical Letters, 2024, 35(9): 109422-. doi: 10.1016/j.cclet.2023.109422
3. [3]
  Liangyu Zhang , Lei Lei , Zhuangzhuang Zhao , Guizhi Yang , Kaitao Wang , Liying Wang , Ningxin Zhang , Yanjia Ai , Xinqing Ma , Guannan Liu , Meng Zhao , Jun Wu , Dongjun Lin , Chun Chen . Enhanced venetoclax delivery using l-phenylalanine nanocarriers in acute myeloid leukemia treatment. Chinese Chemical Letters, 2025, 36(6): 110316-. doi: 10.1016/j.cclet.2024.110316
4. [4]
  Zengzhen Chen , Lirong Zhao , Wenna Guo , Longfei Tan , Qiong Wu , Changhui Fu , Xiangling Ren , Shiping Yu , Xiaowei Chen , Nam-Young Kim , Guihua Jiang , Xianwei Meng . Microwave-sensitive Al-based nano-immunoadjuvant for strengthened tumor microwave-immunotherapy via programmed activation of NLRP3-mediated pyroptosis. Chinese Chemical Letters, 2026, 37(3): 111299-. doi: 10.1016/j.cclet.2025.111299
5. [5]
  Kun-Heng Li , Hong-Yang Zhao , Dan-Dan Wang , Ming-Hui Qi , Zi-Jian Xu , Jia-Mi Li , Zhi-Li Zhang , Shi-Wen Huang . Mitochondria-targeted nano-AIEgens as a powerful inducer for evoking immunogenic cell death. Chinese Chemical Letters, 2024, 35(5): 108882-. doi: 10.1016/j.cclet.2023.108882
6. [6]
  Yanjun Cai , Yong Jiang , Yu Chen , Erzhuo Cheng , Yuan Gu , Yuwei Li , Qianqian Liu , Jian Zhang , Jifang Liu , Shisong Han , Bin Yang . Amplifying STING activation and immunogenic cell death by metal-polyphenol coordinated nanomedicines for enhanced cancer immunotherapy. Chinese Chemical Letters, 2025, 36(5): 110437-. doi: 10.1016/j.cclet.2024.110437
7. [7]
  Ning Tian , Haoyu Ju , Qian Hu , Qifeng Hou , Yiping Lu , Yu Liu , Jinmei Huang , Zhong-Hong Zhu , Bin Zhang , Jin Huang , Ming-Hua Zeng . Solvothermal domino synthesis of an ER-targeted iron(Ⅱ) complex for inducing immunogenic cell death. Chinese Chemical Letters, 2026, 37(6): 111038-. doi: 10.1016/j.cclet.2025.111038
8. [8]
  Xiaopeng Han , Jiayin Li , Fei Li , Zhongyue Yuan , Hao Li , Lei Yang , Yan-Ming Xia , Chao Teng , Chao Qin , Lifang Yin . ROS-sensitive dihydroartemisinin prodrug amplify chemo-immunotherapy efficacy of doxorubicin by coordinating robust tumor cell immunogenic cell death and PD-L1 blockade. Chinese Chemical Letters, 2026, 37(2): 111335-. doi: 10.1016/j.cclet.2025.111335
9. [9]
  Xin Li , Fei Xiong , Xudong Cao , Wei Liu , Haobo Chen , Jiayu He , Weina Zhang , Longguang Tang , Wei Huang , Xikuang Yao . CD44-targeting and ZIF-8 gated gold nanocage for programmed breast cancer therapy through Pt-induced immunogenic cell death. Chinese Chemical Letters, 2026, 37(1): 110970-. doi: 10.1016/j.cclet.2025.110970
10. [10]
  Muhammad Nafees , Muhammad Hanif , Piaoping Yang . Metallodrugs: From mere cytotoxic agents to immune modulators and checkpoint inhibitors. Chinese Chemical Letters, 2026, 37(4): 111013-. doi: 10.1016/j.cclet.2025.111013
11. [11]
  Xue-Jiao Wang , Jun-Li Xin , Hong Xiang , Ze-Yu Zhao , Yu-Hang He , Haibo Wang , Guangyao Mei , Yi-Cheng Mao , Juan Xiong , Jin-Feng Hu . Holotrichones A and B, potent anti-leukemic lindenane-type sesquiterpene trimers with unprecedented complex carbon skeletons from a rare Chloranthus species. Chinese Chemical Letters, 2024, 35(12): 109682-. doi: 10.1016/j.cclet.2024.109682
12. [12]
  Xinyue Lan , Junguang Liang , Churan Wen , Xiaolong Quan , Huimin Lin , Qinqin Xu , Peixian Chen , Guangyu Yao , Dan Zhou , Meng Yu . Photo-manipulated polyunsaturated fatty acid-doped liposomal hydrogel for flexible photoimmunotherapy. Chinese Chemical Letters, 2024, 35(4): 108616-. doi: 10.1016/j.cclet.2023.108616
13. [13]
  Liangliang Jia , Ye Hong , Xinyu He , Ying Zhou , Liujiao Ren , Hongjun Du , Bin Zhao , Bin Qin , Zhe Yang , Di Gao . Fighting hypoxia to improve photodynamic therapy-driven immunotherapy: Alleviating, exploiting and disregarding. Chinese Chemical Letters, 2025, 36(2): 109957-. doi: 10.1016/j.cclet.2024.109957
14. [14]
  Yunyan Li , Zimin Cai , Zhicheng Wang , Sifeng Zhu , Wendian Liu , Cheng Wang . Construction of biomimetic hybrid nanovesicles based on M1 macrophage-derived exosomes for therapy of cancer. Chinese Chemical Letters, 2025, 36(4): 109942-. doi: 10.1016/j.cclet.2024.109942
15. [15]
  Xueying Shi , Xiaoxuan Zhou , Bing Xiao , Hongxia Xu , Wei Zhang , Hongjie Hu , Shiqun Shao , Zhuxian Zhou , Youqing Shen , Xiaodan Xu , Jianbin Tang . A β-lapachone-loaded iron-polyphenol nanocomplex enhances chemodynamic therapy through cascade amplification of ROS in tumor. Chinese Chemical Letters, 2025, 36(5): 110178-. doi: 10.1016/j.cclet.2024.110178
16. [16]
  Qiuyue Lu , Min Shan , Jiaqi Yang , Zhongren Xu , Yueyue Lei , Wukun Liu . A dinuclear gold(I) complex with bis(N-heterocyclic carbene) ligands potentiated immune responses against liver cancer via ROS-driven endoplasmic reticulum stress and ferroptosis. Chinese Chemical Letters, 2025, 36(12): 110940-. doi: 10.1016/j.cclet.2025.110940
17. [17]
  Tengfei Zhang , Chen Han , Chiyuan Wei , Xing Wang , Zhihui Jia , Hong-Min Meng , Zhaohui Li . Ratiometric fluorescence probe using semiconducting polymer nanoparticles and carbon dots for predicting anti-cancer efficiency. Chinese Chemical Letters, 2026, 37(3): 111566-. doi: 10.1016/j.cclet.2025.111566
18. [18]
  Dou Zhang , Xinyi Cai , Yimin Li , Yong Liu , Long Qiu , Zhenying Diao , Xuyi Liu , Yuta Nishina , Yajuan Zou , Jianbo Sun , Shujing Liang , Daxiang Cui , Ting Yin . Nanozyme with dual enzyme activity mediating cascade catalytic therapy synergize multiple functions for antitumor therapy. Chinese Chemical Letters, 2026, 37(3): 111569-. doi: 10.1016/j.cclet.2025.111569
19. [19]
  Xiaoxuan Zhou , Qiuhui Hu , Chengbin He , Yue Qian , Xiaodan Xu , Jianbin Tang , Hongjie Hu . Ferrocene-integrated hypericin self-assembly nanocomplex directs ferroptosis for enhanced cascade tumor photodynamic therapy and immune effects. Chinese Chemical Letters, 2026, 37(7): 111645-. doi: 10.1016/j.cclet.2025.111645
20. [20]
  Zhengyi Shi , Jie Yin , Yang Xiao , Zhangrong Hou , Fei Song , Jianping Wang , Qingyi Tong , Changxing Qi , Yonghui Zhang . Unprecedented sesquiterpene-polycyclic polyprenylated acylphloroglucinol adduct against acute myeloid leukemia via inhibiting mitochondrial complex Ⅴ. Chinese Chemical Letters, 2024, 35(10): 109458-. doi: 10.1016/j.cclet.2023.109458

Get Citation

PDF

XML

Metrics

PDF Downloads(0)
Abstract views(12)
HTML views(0)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142